MELYSSA VAN DER STUYF: Open Payments
NPI 1174069728 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 19 payments from 11 companies in 2025. Trend: 2023 $748 · 2024 $476 · 2025 $562
Food & beverage: $469Education: $93
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Merck Sharp & Dohme LLC | 6 | $119 |
| Astellas Pharma US Inc | 1 | $93 |
| Genentech USA, Inc. | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Lilly USA, LLC | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $26 |
| BeOne Medicines USA, Inc. | 1 | $23 |
| Celgene Corporation | 1 | $19 |
Products named: ENHERTU, KEYTRUDA, KISQALI, VERZENIO, TALVEY, Columvi, BRUKINSA, OPDIVO.
Industry payments across IL — which companies pay providers there.
